InvestorsHub Logo
icon url

ClosetInvestor

08/27/21 9:45 AM

#181023 RE: JPG77 #181020

“Tony C "left" after being demoted due to incompetence.”

Where are the facts go support that?

Here are some facts: NP has been telling us since 2018 that the combo BLA was going to be filed soon. It’s fall of 2021.

“CytoDyn remains on track to complete its filing of a biologics license application (BLA) for PRO 140 as a combination therapy for HIV patients with the FDA by the first quarter of 2019.”

https://www.cytodyn.com/newsroom/press-releases/detail/297/cytodyns-pro-140-leronlimab-hiv-monotherapy-trial
icon url

3X Charm

08/27/21 4:56 PM

#181195 RE: JPG77 #181020

Funny how the recorded elements are ignored and the only material sourced is from the proven liar, NP.

Ken Van Ness is the only name in “black and white” recorded in CYDY SEC filed documents associated with the procurement of Pro 140. No production of NP can be found, save for his own claims.

Tony C was the top executive during the HIV trial success. The calendar proves it as do Naders own quotes as to who was in charge at that time.

Noddor then epically flubbed the HIV BLA, receiving a rare RTF. Most drugs receiving an RTF are not approved. This can be be fact checked.

Tony C resigned on his own accord. The reason are documented in the NP self enrichment lawsuit…all for anyone to fact check. The magistrate in Delaware cited NP for “ unmitigated greed” for “masterminding” this money grab, which cost CYDY shareholders $4.1 million. There is no record to report a contrary case for him leaving.

In fact, as soon as TC left CYDY as COB, NP and Co. instituted the self enrichment scheme in violation of the compensation plan established by TC to provide corporate governance.